Maxizymes, Novel Allosterically Controllable Ribozymes, Can Be Designed To Cleave Various Substrates
- 10 February 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 1 (1), 108-117
- https://doi.org/10.1021/bm990009x
Abstract
We demonstrated previously that an allosterically controllable novel ribozyme, designated the maxizyme, is a powerful tool for disruption of an abnormal chimeric RNA target [BCR-ABL (b2a2) mRNA], and we proposed that it might provide the basis for future gene therapy for the treatment of chronic myelogenous leukemia (Kuwabara et al. Mol. Cell 1998, 2, 617−627). The maxizyme has sensor arms that can recognize a specific sequence and, in the presence exclusively of such a specific sequence, it can form a cavity for capture of catalytically indispensable Mg2+ ions. Cleavage of the target RNA then occurs at a site distant from the specific sequence. Clearly, the specific sequences recognized by sensor arms should not be limited to those of the above mentioned abnormal chimeric target. Thus, to demonstrate the general applicability of maxizyme technology, we constructed maxizymes targeted to other mRNAs, such as PML-RARα mRNA, sDLST mRNA, and BCR-ABL (b1a2) mRNA, that are not cleaved with high specificity by the wild-type hammerhead ribozyme. Specific and efficient cleavage in vitro of these mRNAs by the custom-designed maxizymes demonstrated clearly that maxizyme technology is not limited to a specific case but may have broad general applicability in molecular biology and, also, in a clinical setting.Keywords
This publication has 38 references indexed in Scilit:
- Structure, folding and catalysis of the small nucleolytic ribozymesCurrent Opinion in Structural Biology, 1999
- Formation of a catalytically active dimer by tRNAVal -driven short ribozymesNature Biotechnology, 1998
- A Polypeptide Derived from Mitochondrial Dihydrolipoamide Succinyltransferase Is Located on the Plasma Membrane in Skeletal MuscleBiochemical and Biophysical Research Communications, 1997
- Hammerhead Minizymes with High Cleavage Activity: A Dimeric Structure as the Active Conformation of MinizymesJournal of the American Chemical Society, 1996
- Generality of the NUX Rule: Kinetic Analysis of the Results of Systematic Mutations in the Trinucleotide at the Cleavage Site of Hammerhead RibozymesBiochemistry, 1995
- Kinetic evidence based on solvent isotope effects for the nonexistence of a proton-transfer process in reactions catalyzed by a hammerhead ribozyme: Implication to the double-metal-ion mechanism of catalysisJournal of the American Chemical Society, 1995
- Isolation, Characterization and Structural Organization of the Gene and Pseudogene for the Dihydrolipoamide Succinyltransferase Component of the Human 2‐Oxoglutarate Dehydrogenase ComplexEuropean Journal of Biochemistry, 1994
- The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RARCell, 1991
- Heterogeneous initiation due to slippage at the bacteriophage 82 late gene promoter in vitroBiochemistry, 1990
- Cleavage of specific sites of RNA by designed ribozymesFEBS Letters, 1988